← Back to Search

Unknown

BMS-986172 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by Bristol-Myers Squibb
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 28 days
Awards & highlights

Summary

This trial is testing a new drug called BMS-986172 to see if it is safe, how well people tolerate it, and how food affects its absorption. The study likely involves healthy volunteers or a general population.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 28 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of clinically significant changes in ECG parameters: QTcF

Trial Design

4Treatment groups
Experimental Treatment
Group I: Part D: FE/BAExperimental Treatment1 Intervention
FE/BA = Food Effect/Relative Bioavailability
Group II: Part C: JMADExperimental Treatment2 Interventions
JMAD= Japanese Multiple Ascending Dose
Group III: Part B: MADExperimental Treatment2 Interventions
MAD = Multiple Ascending Dose
Group IV: Part A: SADExperimental Treatment2 Interventions
SAD = Single Ascending Dose
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BMS-986172
2021
Completed Phase 1
~40

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Bristol-Myers SquibbLead Sponsor
2,678 Previous Clinical Trials
4,125,605 Total Patients Enrolled
~9 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top